Explore

Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Stem Cell Therapies
Trendline Trendline
Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting

Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting

Factor Bioscience to Present Seven Innovations at ASGCT Annual Meeting
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy
Trendline Trendline
Alloy Therapeutics and IPI Collaborate to Enhance Antibody Discovery

Alloy Therapeutics and IPI Collaborate to Enhance Antibody Discovery

Alloy Therapeutics and IPI Collaborate to Enhance Antibody Discovery
Trendline Trendline
4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA

4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA

4basebio Expands with New Innovation Hub in Cambridge to Meet Growing Demand for Synthetic DNA
Trendline Trendline
Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks
Trendline Trendline
Eascra Biotech Appoints Dr. Anne Yau to Advance RNA Therapeutics for Musculoskeletal Diseases

Eascra Biotech Appoints Dr. Anne Yau to Advance RNA Therapeutics for Musculoskeletal Diseases

Eascra Biotech Appoints Dr. Anne Yau to Advance RNA Therapeutics for Musculoskeletal Diseases
Discover daily Discover daily
Today Marks a Revolutionary-Era Home for Arts and Sciences

Today Marks a Revolutionary-Era Home for Arts and Sciences

The American Academy of Arts and Sciences, one of the oldest learned societies in the United States, was founded in 1780 during the American Revolu...
Trendline Trendline
Eascra Biotech Advances Nanomedicine with New Research Scientist Appointment

Eascra Biotech Advances Nanomedicine with New Research Scientist Appointment

Eascra Biotech Advances Nanomedicine with New Research Scientist Appointment
Trendline Trendline
Pharmaceutical Industry Utilizes Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Industry Utilizes Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Industry Utilizes Protein Biomarkers to Mitigate Drug Development Risks
Trendline Trendline
Big Tech Companies Innovate Drug Discovery with AI Platforms

Big Tech Companies Innovate Drug Discovery with AI Platforms

Big Tech Companies Innovate Drug Discovery with AI Platforms